Novartis Revenue 2024

Novartis Revenue

49.08 B USD

Novartis Dividend yield

3.3 %

Ticker

NOVN.SW

ISIN

CH0012005267

WKN

904278

In 2024, Novartis's sales reached 49.08 B USD, a 5.19% difference from the 46.66 B USD sales recorded in the previous year.

The Novartis Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e52.9465,44
2028e51.6267,10
2027e51.9466,69
2026e51.9566,68
2025e51.1167,78
2024e49.0870,57
202346.6674,24
202243.3874,15
202143.9774,10
202049.971,14
201948.6271,35
201846.0270,54
201743.3669,06
201649.3964,89
201550.3665,99
201453.6367,66
201358.8366,67
201257.5667,42
201159.3868,03
201051.5671,90
200945.173,00
200842.5873,14
200738.9571,67
200636.7571,97
200532.5372,74
200428.2576,55

Novartis Aktienanalyse

What does Novartis do?

Novartis AG is a globally active company operating in the pharmaceutical, ophthalmology, and generics manufacturing sectors. The company, headquartered in Basel, Switzerland, was founded in 1996 and originated from a merger between Ciba-Geigy and Sandoz. Novartis AG is now a leading company worldwide in the research, development, production, and marketing of pharmaceuticals and other health products. Novartis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Novartis's Sales Figures

The sales figures of Novartis originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Novartis’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Novartis's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Novartis’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Novartis Stock

How much revenue did Novartis generate this year?

Novartis has achieved a revenue of 49.08 B USD this year.

How much was the turnover of the company Novartis compared to the previous year?

The revenue of Novartis has increased by 5.19% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Novartis?

The revenue of Novartis is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Novartis measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Novartis so important for investors?

The revenue of Novartis is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Novartis pay?

Over the past 12 months, Novartis paid a dividend of 3.2 USD . This corresponds to a dividend yield of about 3.3 %. For the coming 12 months, Novartis is expected to pay a dividend of 3.28 USD.

What is the dividend yield of Novartis?

The current dividend yield of Novartis is 3.3 %.

When does Novartis pay dividends?

Novartis pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Novartis?

Novartis paid dividends every year for the past 26 years.

What is the dividend of Novartis?

For the upcoming 12 months, dividends amounting to 3.28 USD are expected. This corresponds to a dividend yield of 3.43 %.

In which sector is Novartis located?

Novartis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Novartis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Novartis from 3/11/2024 amounting to 3.3 USD, you needed to have the stock in your portfolio before the ex-date on 3/7/2024.

When did Novartis pay the last dividend?

The last dividend was paid out on 3/11/2024.

What was the dividend of Novartis in the year 2023?

In the year 2023, Novartis distributed 3.1 USD as dividends.

In which currency does Novartis pay out the dividend?

The dividends of Novartis are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Novartis stock can be added to a savings plan with the following providers: ING

Andere Kennzahlen von Novartis

Our stock analysis for Novartis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novartis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.